Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 1:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2305–2328 of 196,835 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: ALL Clear all

Conditions: Infantile Spasms
Interventions: Ganaxolone, Placebo; Drug · Other
Lead sponsor: Marinus Pharmaceuticals; Industry
Eligibility: 4 Months to 24 Months
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 15
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Miami, Florida + 10 more

Conditions: Breast Cancer
Interventions: Daily Radiation Therapy, Weekly Radiation Therapy; Radiation
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 412 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 3
States / cities: New York, New York

Conditions: Distorted Balance, Low Back Pain
Interventions: chiropractic, physical therapy; Other
Lead sponsor: Logan College of Chiropractic; Other
Eligibility: 60 Years to 85 Years
Enrollment: 169 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Chesterfield, Missouri

Conditions: Diabetic Peripheral Neuropathy
Interventions: Mazisotine, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 404 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 34
States / cities: Chandler, Arizona • Scottsdale, Arizona • Tucson, Arizona + 30 more

Conditions: Posttraumatic Stress Disorder
Interventions: Pregnenolone, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Polycythemia Vera, Essential Thrombocytosis, Idiopathic Myelofibrosis, Neutrophils, Chronic Myeloproliferative Disorders
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Insulin Resistance
Interventions: 4,000 IU vitamin D3; Dietary Supplement
Lead sponsor: University of Missouri-Columbia; Other
Eligibility: 9 Years to 19 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Columbia, Missouri

Conditions: Human Immunodeficiency Virus
Interventions: Initiation of anti-retroviral therapy; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2014
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Atrial Fibrillation
Interventions: Portable ECG monitor; Diagnostic Test
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: Not listed
Enrollment: 245 participants
Timeline: 2018
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Cervical Cancer, Precancerous Condition
Interventions: Mindfulness-Based Stress Reduction, Healthy Lifestyles; Behavioral
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2014
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Mild Traumatic Brain Injury, Distress-based Psychopathology, Chronic Pain
Interventions: Acceptance and Commitment Therapy; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 75 Years
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Public Speaking, Social Fear
Interventions: Exposure w/ Acceptance-Based Rationale, Exposure w/ Habituation-Based Rationale; Behavioral
Lead sponsor: Drexel University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Multiple Sclerosis
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 858 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2014
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Liver Metastases, Colorectal Carcinoma
Interventions: Tilmanocept (Technetium Tc 99m tilmanocept Injection), SPECT/CT Imaging; Drug · Procedure
Lead sponsor: Navidea Biopharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Sepsis, Hypotension
Interventions: Drotrecogin Alfa (Activated), placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Loma Linda, California

Conditions: Kidney Transplant Rejection
Interventions: Not listed
Lead sponsor: Verici Dx; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 9
States / cities: Chicago, Illinois • Evanston, Illinois • Baltimore, Maryland + 6 more

Conditions: Heart Repolarization
Interventions: Naltrexone HCl/bupropion HCl, Placebo, Moxifloxacin; Drug · Other
Lead sponsor: Orexigen Therapeutics, Inc; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Asthma, Copd, Acute Exacerbation of COPD
Interventions: Inhaler Trainer System, Initial Inhaler Use Assessment, Inhaler Use Instruction; Device · Other
Lead sponsor: Koronis Biomedical Technologies; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Arrhythmias, Cardiac
Interventions: Reveal® DX or Reveal® XT Insertable Cardiac Monitor; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: 18 Years and older
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2011
U.S. locations: 9
States / cities: La Jolla, California • Miramar, Florida • Macon, Georgia + 6 more

Conditions: Circulating Tumor DNA, Cancer, Neoplasms, Genomic Testing, Genomic Alterations
Interventions: Not listed
Lead sponsor: Foundation Medicine; Industry
Eligibility: 18 Years and older
Enrollment: 1,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Cambridge, Massachusetts

Conditions: Parathyroid Diseases, Parathyroid Dysfunction, Parathyroid Neoplasms, Parathyroid Adenoma, Hypercalcemia, Neoplasms, Glandular and Epithelial, Endocrine Gland Neoplasms, Adenoma, Hyperparathyroidism, Hyperparathyroidism, Primary
Interventions: Parathyroid Eye (PTeye); Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Cardiovascular Diseases, Peripheral Vascular Diseases
Interventions: Exercise, Diet; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: Not listed
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Mesothelioma
Interventions: Carboplatin, Bevacizumab and Pemetrexed; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Major Depressive Disorder (MDD)
Interventions: Active Closed Loop Real Time fMRI Neurofeedback, Sham Closed Loop Real Time fMRI Neurofeedback; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Search by objective public record fields.

A Randomized, Controlled Trial of Ganaxolone in Patients With Infantile Spasms

Study Comparing Whole Breast Radiotherapy With a Daily Versus a Weekly Tumor

Geriatrics Balance and Low Back Pain Study

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Neurosteroids for Treatment of PTSD in Veterans

Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders

Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents

Tissue Drug Levels of HIV Medications

Atrial Fibrillation Screening in Nursing Homes

The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia

One-Day Life Skills Workshop for Veterans With TBI, Pain and Psychopathology

Exposure With Acceptance-Based Versus Habituation-Based Rationale for Public Speaking Anxiety

Biomarkers in Multiple Sclerosis

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Extended Therapy of Drotrecogin Alfa (Activated) 4 vs 7 Days Infusion

Validation of Genomic Immune-phenotyping Profiles to Predict Risk of Kidney Transplant Rejection

Study to Evaluate the Effect of Naltrexone and Bupropion Extended-Release Combination on Cardiac Repolarization in Healthy Participants

Inhaler Trainer Efficacy Study

Reveal In-Office Implants

Concordance Between ctDNA Assay and FoundationOne

Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

Improving Functioning in Peripheral Arterial Disease

Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)

Neurofeedback to Treat Depression - 2